Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production

Macrophages activate the production of cytokines and chemokines in response to LPS through signaling cascades downstream from TLR4. Lipid mediators such as PGE(2), which are produced during inflammatory responses, have been shown to suppress MyD88-dependent gene expression upon TLR4 activation in ma...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 180; no. 4; pp. 2125 - 2131
Main Authors Xu, X Julia, Reichner, Jonathan S, Mastrofrancesco, Balduino, Henry, Jr, William L, Albina, Jorge E
Format Journal Article
LanguageEnglish
Published United States 15.02.2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Macrophages activate the production of cytokines and chemokines in response to LPS through signaling cascades downstream from TLR4. Lipid mediators such as PGE(2), which are produced during inflammatory responses, have been shown to suppress MyD88-dependent gene expression upon TLR4 activation in macrophages. The study reported here investigated the effect of PGE(2) on TLR3- and TLR4-dependent, MyD88-independent gene expression in murine J774A.1 macrophages, as well as the molecular mechanism underlying such an effect. We demonstrate that PGE(2) strongly suppresses LPS-induced IFN-beta production at the mRNA and protein levels. Poly (I:C)-induced IFN-beta and LPS-induced CCL5 production were also suppressed by PGE(2). The inhibitory effect of PGE(2) on LPS-induced IFN-beta expression is mediated through PGE(2) receptor subtypes EP(2) and EP(4), and mimicked by the cAMP analog 8-Br-cAMP as well as by the adenylyl cyclase activator forskolin. The downstream effector molecule responsible for the cAMP-induced suppressive effect is exchange protein directly activated by cAMP (Epac) but not protein kinase A. Moreover, data demonstrate that Epac-mediated signaling proceeds through PI3K, Akt, and GSK3beta. In contrast, PGE(2) inhibits LPS-induced TNF-alpha production in these cells through a distinct pathway requiring protein kinase A activity and independent of Epac/PI3K/Akt. In vivo, administration of a cyclooxygenase inhibitor before LPS injection resulted in enhanced serum IFN-beta concentration in mice. Collectively, data demonstrate that PGE(2) is a negative regulator for IFN-beta production in activated macrophages and during endotoxemia.
AbstractList Macrophages activate the production of cytokines and chemokines in response to LPS through signaling cascades downstream from TLR4. Lipid mediators such as PGE(2), which are produced during inflammatory responses, have been shown to suppress MyD88-dependent gene expression upon TLR4 activation in macrophages. The study reported here investigated the effect of PGE(2) on TLR3- and TLR4-dependent, MyD88-independent gene expression in murine J774A.1 macrophages, as well as the molecular mechanism underlying such an effect. We demonstrate that PGE(2) strongly suppresses LPS-induced IFN-beta production at the mRNA and protein levels. Poly (I:C)-induced IFN-beta and LPS-induced CCL5 production were also suppressed by PGE(2). The inhibitory effect of PGE(2) on LPS-induced IFN-beta expression is mediated through PGE(2) receptor subtypes EP(2) and EP(4), and mimicked by the cAMP analog 8-Br-cAMP as well as by the adenylyl cyclase activator forskolin. The downstream effector molecule responsible for the cAMP-induced suppressive effect is exchange protein directly activated by cAMP (Epac) but not protein kinase A. Moreover, data demonstrate that Epac-mediated signaling proceeds through PI3K, Akt, and GSK3beta. In contrast, PGE(2) inhibits LPS-induced TNF-alpha production in these cells through a distinct pathway requiring protein kinase A activity and independent of Epac/PI3K/Akt. In vivo, administration of a cyclooxygenase inhibitor before LPS injection resulted in enhanced serum IFN-beta concentration in mice. Collectively, data demonstrate that PGE(2) is a negative regulator for IFN-beta production in activated macrophages and during endotoxemia.
Abstract Macrophages activate the production of cytokines and chemokines in response to LPS through signaling cascades downstream from TLR4. Lipid mediators such as PGE2, which are produced during inflammatory responses, have been shown to suppress MyD88-dependent gene expression upon TLR4 activation in macrophages. The study reported here investigated the effect of PGE2 on TLR3- and TLR4-dependent, MyD88-independent gene expression in murine J774A.1 macrophages, as well as the molecular mechanism underlying such an effect. We demonstrate that PGE2 strongly suppresses LPS-induced IFN-β production at the mRNA and protein levels. Poly (I:C)-induced IFN-β and LPS-induced CCL5 production were also suppressed by PGE2. The inhibitory effect of PGE2 on LPS-induced IFN-β expression is mediated through PGE2 receptor subtypes EP2 and EP4, and mimicked by the cAMP analog 8-Br-cAMP as well as by the adenylyl cyclase activator forskolin. The downstream effector molecule responsible for the cAMP-induced suppressive effect is exchange protein directly activated by cAMP (Epac) but not protein kinase A. Moreover, data demonstrate that Epac-mediated signaling proceeds through PI3K, Akt, and GSK3β. In contrast, PGE2 inhibits LPS-induced TNF-α production in these cells through a distinct pathway requiring protein kinase A activity and independent of Epac/PI3K/Akt. In vivo, administration of a cyclooxygenase inhibitor before LPS injection resulted in enhanced serum IFN-β concentration in mice. Collectively, data demonstrate that PGE2 is a negative regulator for IFN-β production in activated macrophages and during endotoxemia.
Author Mastrofrancesco, Balduino
Albina, Jorge E
Reichner, Jonathan S
Henry, Jr, William L
Xu, X Julia
Author_xml – sequence: 1
  givenname: X Julia
  surname: Xu
  fullname: Xu, X Julia
  email: Julia_Xu@brown.edu
  organization: Division of Surgical Research, Department of Surgery, Rhode Island Hospital and Warren Alpert Medical School, Brown University, 593 Eddy Street, Providence, RI 02903, USA. Julia_Xu@brown.edu
– sequence: 2
  givenname: Jonathan S
  surname: Reichner
  fullname: Reichner, Jonathan S
– sequence: 3
  givenname: Balduino
  surname: Mastrofrancesco
  fullname: Mastrofrancesco, Balduino
– sequence: 4
  givenname: William L
  surname: Henry, Jr
  fullname: Henry, Jr, William L
– sequence: 5
  givenname: Jorge E
  surname: Albina
  fullname: Albina, Jorge E
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18250418$$D View this record in MEDLINE/PubMed
BookMark eNpFkEtLw0AUhQep2If-AkGycpd655nJUkqrhfpY6HqYZG40JS8zyaL_3imtuLpwOOdczjcnk6ZtkJBbCksBIn3Yl3U9Nm21pDooS0aZvCAzKiXESoGakBkAYzFNVDIlc-_3AKCAiSsypZpJEFTPyMt73_rBflW2cWUTrVnkx67r0Xv0UVV2bddWB2_z_Nv2pcPYD2U9VnZAF203r3GGg426vnVjPpRtc00uC1t5vDnfBfncrD9Wz_Hu7Wm7etzFOVNcxqlF7VjOC0WTDJCJBDkKyHJLZaa1ppi6IpGpBKmKzNJMIA-qAy6CVSV8Qe5PveH1z4h-MHXpc6zCCmxHbxJgSgoNwchPxjzM9D0WpuvL2vYHQ8EcKZo_iiZQNMIcKYbU3bl-zGp0_5kzNv4LIDxypw
CitedBy_id crossref_primary_10_1074_jbc_M110_154971
crossref_primary_10_3389_fphys_2017_00089
crossref_primary_10_1165_rcmb_2008_0091TR
crossref_primary_10_4049_jimmunol_1301912
crossref_primary_10_1073_pnas_1602023113
crossref_primary_10_1016_j_immuni_2014_02_009
crossref_primary_10_1111_j_1476_5381_2008_00056_x
crossref_primary_10_1038_nri3787
crossref_primary_10_1073_pnas_1121131109
crossref_primary_10_1016_j_lfs_2010_11_015
crossref_primary_10_1016_j_anireprosci_2018_11_010
crossref_primary_10_1016_j_prostaglandins_2018_10_002
crossref_primary_10_1097_j_pain_0000000000000341
crossref_primary_10_1111_j_1476_5381_2009_00162_x
crossref_primary_10_1100_2012_748572
crossref_primary_10_1111_aji_13248
crossref_primary_10_1111_j_1476_5381_2008_00087_x
crossref_primary_10_1155_2019_3451461
crossref_primary_10_1016_j_cyto_2020_155241
crossref_primary_10_1016_j_phrs_2020_105030
crossref_primary_10_1016_j_bbalip_2018_07_003
crossref_primary_10_1038_s41467_020_14945_2
crossref_primary_10_1016_j_cellsig_2011_03_007
crossref_primary_10_1016_j_stemcr_2016_03_006
crossref_primary_10_1038_mt_2015_172
crossref_primary_10_1134_S000629791109001X
crossref_primary_10_1186_1477_7827_7_55
crossref_primary_10_18632_oncotarget_10305
crossref_primary_10_2147_JPR_S385617
crossref_primary_10_1016_j_toxicon_2023_107288
crossref_primary_10_1111_bph_15412
crossref_primary_10_1016_j_plefa_2018_01_004
crossref_primary_10_1097_ICO_0b013e318242fd7c
crossref_primary_10_1002_jcp_27271
crossref_primary_10_1038_s41590_018_0243_7
crossref_primary_10_1016_j_aquaculture_2018_08_078
crossref_primary_10_1093_femsre_fuaa066
crossref_primary_10_1152_physrev_00025_2017
crossref_primary_10_1089_ars_2013_5750
crossref_primary_10_1111_j_1582_4934_2011_01413_x
crossref_primary_10_1038_ncomms3657
crossref_primary_10_1136_bjophthalmol_2018_313587
crossref_primary_10_4049_jimmunol_2001325
crossref_primary_10_1038_s41423_020_00541_3
crossref_primary_10_1111_j_1365_2036_2011_04784_x
crossref_primary_10_1146_annurev_pharmtox_010909_105714
crossref_primary_10_4137_LPI_S1000
crossref_primary_10_4049_jimmunol_1601073
crossref_primary_10_1128_IAI_01349_08
crossref_primary_10_1016_j_fsi_2023_109090
crossref_primary_10_1016_j_theriogenology_2015_01_032
crossref_primary_10_1038_cmi_2016_25
crossref_primary_10_1097_CCM_0b013e3182416f05
crossref_primary_10_3389_fimmu_2016_00123
crossref_primary_10_1210_en_2008_1379
crossref_primary_10_1136_bmjopen_2012_001330
crossref_primary_10_1007_s00424_009_0747_y
crossref_primary_10_1111_j_1365_3024_2011_01345_x
crossref_primary_10_3390_ijms18122725
crossref_primary_10_1111_j_1476_5381_2009_00458_x
crossref_primary_10_1016_j_fsi_2014_11_023
crossref_primary_10_1186_s12974_019_1468_6
crossref_primary_10_1016_j_plipres_2010_07_005
crossref_primary_10_1002_JLB_3MIR1017_400R
crossref_primary_10_1089_jir_2014_0227
crossref_primary_10_1128_microbiolspec_MCHD_0035_2016
crossref_primary_10_1038_srep46165
crossref_primary_10_1517_14656566_2012_699959
crossref_primary_10_4049_jimmunol_1801010
Cites_doi 10.1016/S1471-4906(03)00139-X
10.1016/S0090-6980(02)00054-0
10.1146/annurev.nutr.18.1.353
10.1074/jbc.275.17.13026
10.4049/jimmunol.174.2.595
10.1189/jlb.0303116
10.1016/0014-5793(95)00421-5
10.1038/24884
10.1016/S0021-9258(18)53022-2
10.1111/j.1749-6632.1994.tb52729.x
10.1084/jem.174.6.1549
10.1016/S0021-9258(19)84425-3
10.1073/pnas.80.13.3923
10.1002/jlb.67.3.405
10.1038/378785a0
10.1074/jbc.M110856200
10.1016/S1074-7613(00)80086-2
10.1152/physiolgenomics.00128.2004
10.1128/mcb.10.4.1329-1337.1990
10.1016/0006-291X(86)91224-6
10.1038/35017574
10.1016/S0163-7827(00)00008-4
10.1074/jbc.M109440200
10.1074/jbc.M409816200
10.1006/bbrc.1998.9540
10.1016/S0021-9258(18)60727-6
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.4049/jimmunol.180.4.2125
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 2131
ExternalDocumentID 10_4049_jimmunol_180_4_2125
18250418
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: R01 GM042859
– fundername: NIGMS NIH HHS
  grantid: GM 42859
– fundername: NIGMS NIH HHS
  grantid: R01 GM042859-17
GroupedDBID ---
-~X
.55
18M
2WC
34G
39C
3O-
53G
5GY
5RE
5VS
79B
85S
AARDX
ABCQX
ABEFU
ABJNI
ABOCM
ABPPZ
ACGFO
ACGFS
ACIWK
ACNCT
ACPRK
ADBBV
ADNWM
AENEX
AFFNX
AFHIN
AFOSN
AFRAH
AHWXS
AIZAD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CGR
CUY
CVF
D0L
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FRP
GX1
H13
IH2
K-O
KQ8
L7B
MVM
NEJ
NPM
OK1
P0W
P2P
PQQKQ
R.V
RHF
RHI
RZQ
SJN
TR2
TWZ
W8F
WH7
WOQ
X7M
XJT
XSW
XTH
YHG
ZE2
ZGI
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c2635-9ae8d2c3f617b0e247e3e40bca15b8881e9df7595056fba1b4e3881d03447e673
ISSN 0022-1767
IngestDate Sun Sep 29 07:26:06 EDT 2024
Thu Sep 26 17:29:22 EDT 2024
Sat Sep 28 08:34:00 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2635-9ae8d2c3f617b0e247e3e40bca15b8881e9df7595056fba1b4e3881d03447e673
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://journals.aai.org/jimmunol/article-pdf/180/4/2125/1257886/zim00408002125.pdf
PMID 18250418
PQID 70265480
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_70265480
crossref_primary_10_4049_jimmunol_180_4_2125
pubmed_primary_18250418
PublicationCentury 2000
PublicationDate 2008-Feb-15
2008-02-15
20080215
PublicationDateYYYYMMDD 2008-02-15
PublicationDate_xml – month: 02
  year: 2008
  text: 2008-Feb-15
  day: 15
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 2008
References 2023010204021463000_R11
2023010204021463000_R10
2023010204021463000_R15
2023010204021463000_R14
2023010204021463000_R13
2023010204021463000_R12
2023010204021463000_R19
2023010204021463000_R18
2023010204021463000_R17
2023010204021463000_R16
2023010204021463000_R22
2023010204021463000_R9
2023010204021463000_R21
2023010204021463000_R8
2023010204021463000_R20
2023010204021463000_R7
2023010204021463000_R6
2023010204021463000_R26
2023010204021463000_R5
2023010204021463000_R25
2023010204021463000_R4
2023010204021463000_R24
2023010204021463000_R3
2023010204021463000_R23
2023010204021463000_R2
2023010204021463000_R1
References_xml – ident: 2023010204021463000_R15
  doi: 10.1016/S1471-4906(03)00139-X
– ident: 2023010204021463000_R12
  doi: 10.1016/S0090-6980(02)00054-0
– ident: 2023010204021463000_R24
  doi: 10.1146/annurev.nutr.18.1.353
– ident: 2023010204021463000_R17
  doi: 10.1074/jbc.275.17.13026
– ident: 2023010204021463000_R14
  doi: 10.4049/jimmunol.174.2.595
– ident: 2023010204021463000_R5
  doi: 10.1189/jlb.0303116
– ident: 2023010204021463000_R21
  doi: 10.1016/0014-5793(95)00421-5
– ident: 2023010204021463000_R13
  doi: 10.1038/24884
– ident: 2023010204021463000_R22
  doi: 10.1016/S0021-9258(18)53022-2
– ident: 2023010204021463000_R20
  doi: 10.1111/j.1749-6632.1994.tb52729.x
– ident: 2023010204021463000_R3
  doi: 10.1084/jem.174.6.1549
– ident: 2023010204021463000_R4
  doi: 10.1016/S0021-9258(19)84425-3
– ident: 2023010204021463000_R9
  doi: 10.1073/pnas.80.13.3923
– ident: 2023010204021463000_R8
  doi: 10.1002/jlb.67.3.405
– ident: 2023010204021463000_R19
  doi: 10.1038/378785a0
– ident: 2023010204021463000_R25
  doi: 10.1074/jbc.M110856200
– ident: 2023010204021463000_R6
  doi: 10.1016/S1074-7613(00)80086-2
– ident: 2023010204021463000_R7
  doi: 10.1152/physiolgenomics.00128.2004
– ident: 2023010204021463000_R10
  doi: 10.1128/mcb.10.4.1329-1337.1990
– ident: 2023010204021463000_R2
  doi: 10.1016/0006-291X(86)91224-6
– ident: 2023010204021463000_R26
  doi: 10.1038/35017574
– ident: 2023010204021463000_R11
  doi: 10.1016/S0163-7827(00)00008-4
– ident: 2023010204021463000_R18
  doi: 10.1074/jbc.M109440200
– ident: 2023010204021463000_R16
  doi: 10.1074/jbc.M409816200
– ident: 2023010204021463000_R23
  doi: 10.1006/bbrc.1998.9540
– ident: 2023010204021463000_R1
  doi: 10.1016/S0021-9258(18)60727-6
SSID ssj0006024
Score 2.260904
Snippet Macrophages activate the production of cytokines and chemokines in response to LPS through signaling cascades downstream from TLR4. Lipid mediators such as...
Abstract Macrophages activate the production of cytokines and chemokines in response to LPS through signaling cascades downstream from TLR4. Lipid mediators...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 2125
SubjectTerms Animals
Cell Line
Dinoprostone - physiology
Dose-Response Relationship, Immunologic
Endotoxemia - immunology
Endotoxemia - metabolism
Gene Expression Regulation - immunology
Interferon-beta - antagonists & inhibitors
Interferon-beta - biosynthesis
Interferon-beta - genetics
Lipopolysaccharides - antagonists & inhibitors
Lipopolysaccharides - pharmacology
Macrophage Activation - immunology
Macrophages - immunology
Macrophages - metabolism
Male
Mice
Myeloid Differentiation Factor 88 - physiology
RNA, Messenger - antagonists & inhibitors
RNA, Messenger - biosynthesis
Signal Transduction - immunology
Title Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production
URI https://www.ncbi.nlm.nih.gov/pubmed/18250418
https://search.proquest.com/docview/70265480
Volume 180
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dj5QwEG_0jMYXo-fX6p3yoE8re1AKlMeL2fU0t6sxuwlvTaElITnZjcDD-dc7Q-HKXs7PF0KatJCZYZhO5_cbQt4ktEiCLIzciHuxywLGXBnywpVMSj9WNNIascPLVXS2YZ_SMLUJ_Q5d0mSz_MeNuJL_0SqMgV4RJfsPmr1aFAbgHvQLV9AwXP9Kx18QsiG7LhxlNZ3Tad3uusJWXU8vyh32P7isZY7IqlJpF77mb9itC2LMj4uVm-lGYn2WMgSy4zDVAsYMpwSCSAxZ09vuSMwbJRDSFtWUdkjrKx__VZf5gKUZEvTTUfq7bsD_Y08PXedbc-5xodqy2trcbA-e6BNCPTpiyE9wLGk2CM0RXsCPTdMN63O9kXGxPQ9qgND935j65idx3dMz2Nmgp-8FMIMFZ2xmJ495tVefxWJzfi7W83R9m9yh4JLQF35IbTFQ5FE28Mrjuxp-KnzIyQ2P2I9hfrEx6QKU9UPyoFeXc2rM5BG5patDctf0Gr08JPeWfRXFY7LcsxtnTh1rN85v7cYZ7MaxdvOEbBbz9fszt2-r4ebIPOQmUnNF86CA4DXzNGWxDjTzslz6YcY593WiijhMMDYuMulnTAcwqjpySB3FwVNyUG0r_Zw4fiw9xcNIBTFyyYWSJRDPRjr3Fe7jkwl5NwhK7Ax7ioBdJ8pVDHIVIFfBBMp1Ql4PwhTg5fDoSlZ629Yi9miEzIQT8szI2C7HkYTP5y_-OPcluW_t84gcNN9bfQwRZZO96ozhJ9wweFE
link.rule.ids 315,783,787,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prostaglandin+E2+suppresses+lipopolysaccharide-stimulated+IFN-beta+production&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Xu%2C+X+Julia&rft.au=Reichner%2C+Jonathan+S&rft.au=Mastrofrancesco%2C+Balduino&rft.au=Henry%2C+William+L&rft.date=2008-02-15&rft.issn=0022-1767&rft.volume=180&rft.issue=4&rft.spage=2125&rft.epage=2131&rft_id=info:doi/10.4049%2Fjimmunol.180.4.2125&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon